STUDY PROTOCOL
Accepted on 21 Jul 2025
Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: A single-center randomized open-label trial (ZAVICONT). Rationale and design
doi 10.3389/fphar.2025.1618987